Sina Salem Ahim

Dr. Sina Salem Ahim

Fasa University of Medical Sciences, Fasā, Fārs, Iran
orcid
MD,researcher,Fasa University of Medical Sciences

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2026 in Metabolism Open
Verified
Journal Article
Open access
Sina Salem AhimSina Salem Ahim
Sina Salem Ahim
MEHRDAD BANDEGIMEHRDAD BANDEGI
MEHRDAD BANDEGI
EGErfan Ghanbarzadeh
Erfan Ghanbarzadeh
Roozbeh Heidarzadeh-PilehroodRoozbeh Heidarzadeh-Pilehrood
Roozbeh Heidarzadeh-Pilehrood
Evidence supporting the involvement of non-coding RNAs (ncRNAs) in neuronal plasticity and susceptibility has been fragmented across different diseases and ncRNA subtypes. We propose an evidence-tiered, axis-based framework integrating microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs) across major neurodegenerative disorders. We have focused on studies that have attempted to establish links between ncRNAs and disease pathogenesis through functional perturbation, validation, and/or rescue in relevant disease models. To facilitate cross-disease comparison, we have categorized these studies along four axes of proteostasis/protein aggregation, neuroinflammation, synaptic/circuit dysfunction, and mitochondrial/autophagy dysfunction. Overall, these ncRNAs have been reported to function as modulators and potential indicators of bioenergetic stress, influencing glial cell function, neuronal survival, metabolic vulnerability, and network plasticity. We have highlighted common regulatory modules, including the role of miRNAs in modulating autophagy and inflammatory-metabolic coupling, lncRNAs in regulating amyloid/synuclein-related processes, and circRNA-mediated miRNA/RBP modules in regulating processes involving mitochondria, while also pointing out discrepancies. We have also discussed the possibility of ncRNA panels and therapeutics, facilitated by advances in delivery strategies, for the discovery of biomarkers and drug targets, while also pointing out some of the challenges that need to be addressed, including heterogeneity of evidence, cell-type specificity, blood–brain barrier constraints, and off-target effects.

7 December 2025 in Journal of Nephropathology
Verified
Journal Article
Open access
PDF file
Sina Salem AhimSina Salem Ahim
Sina Salem Ahim
AEA. Emadzadeh
A. Emadzadeh
SSS. Shamsghahfarokhi
S. Shamsghahfarokhi
IAI.Z. Asoodeh
I.Z. Asoodeh
FRF. Rahbari
F. Rahbari
RAR.J. Arismani
R.J. Arismani
Recovery of renal function and structure following AKI is a complex and multifactorial process involving coordinated tubular epithelial regeneration, resolution of inflammation, restoration of microvascular integrity, and remodeling of the extracellular matrix. Clinical recovery is variable and influenced by injury severity, comorbidities, and therapeutic interventions. Advances in biomarkers and imaging techniques enhance early prediction and monitoring of recovery trajectories. Although no definitive therapies currently exist to reliably speed recovery, promising approaches, including stem cell secretome administration and growth factor modulation, are in development. Long-term consequences of incomplete structural repair highlight the importance of sustained patient followup after apparent recovery from AKI. Keywords: Chronic kidney disease, Acute kidney injury, Renal recovery, Kidney function, Renal structure, Nephron regeneration, Tubular repair, Histology

7 December 2025 in Journal of Parathyroid Disease
Verified
Journal Article
Open access
Sina Salem AhimSina Salem Ahim
Sina Salem Ahim
SASara Aghaei
Sara Aghaei
FBFarzin Banei
Farzin Banei
MMMohammad Mousavi
Mohammad Mousavi
Mohammad ShahsavanMohammad Shahsavan
Mohammad Shahsavan
FNFaezeh Nesaei
Faezeh Nesaei
The brain-gut-bone axis plays a crucial and complex role in regulating bone metabolism, particularly in the context of osteoporosis. This multidirectional communication network integrates signals from several physiological systems, including the gut microbiota, immune system, nervous system, and hormonal environment, all of which collectively influence the balance between bone formation by osteoblasts and bone resorption by osteoclasts. The gut microbiota contributes to this axis by producing metabolites such as short-chain fatty acids (SCFAs) and modulating systemic inflammation, which in turn can affect bone cell activity and mineralization processes. The immune system participates through cytokine signaling that either promotes or inhibits bone resorption and formation, linking inflammation to bone health. Meanwhile, the nervous system, via autonomic and sensory pathways, regulates nutrient absorption, bone blood flow, and directly modulates bone cell function through neuropeptides and neurotransmitters. Hormonal factors, including parathyroid hormone, sex steroids, and gut-derived hormones like serotonin, further modulate bone turnover by fine-tuning osteoblast and osteoclast activity. Disruptions in any component of this axis, such as dysbiosis of the gut microbiota, chronic inflammation, neurotransmitter imbalance, or hormonal deficiencies can lead to dysregulated bone remodeling, favoring increased bone resorption, decreased bone formation, and eventually decreased bone density. This manifests clinically as osteoporosis, characterized by fragile bones and elevated fracture risk. Therefore, understanding and targeting the brain-gut-bone axis presents promising therapeutic opportunities. Interventions such as probiotics, anti-inflammatory therapies, neuromodulation, and hormone replacement can potentially restore the balance in this axis, improving bone health and reducing osteoporosis progression. This integrative approach highlights the importance of systemic interactions and opens new avenues for precision medicine in bone metabolic disorders.

17 October 2025 in Iranian Journal of Burns and Wound Research
Verified
Journal Article
Closed access
SHSeyed Ali Hosseini
Seyed Ali Hosseini
Sina Salem AhimSina Salem Ahim
Sina Salem Ahim
AAAli Aghajan
Ali Aghajan

4 October 2025 in Journal of Parathyroid Disease
Verified
Journal Article
Open access
MRMehrnaz Nazari Rad
Mehrnaz Nazari Rad
HRHamid Rastad
Hamid Rastad
LALeila Ashrafi
Leila Ashrafi
SKSara Ghaseminejad Kermani
Sara Ghaseminejad Kermani
KSKamran Safa
Kamran Safa
BMBaharak Maddahi
Baharak Maddahi
Introduction: Urinary tract infection (UTI) is among the most common bacterial infections in children, and evidently, it is associated with vitamin D deficiency. Accordingly, the present study intended to examine the frequency of vitamin D deficiency in children with UTI. Materials and Methods: Databases Scopus, PubMed, Embase, Web of Science, Cochrane, and Google Scholar Search Engine were used for articles published until August 1, 2025. Data was analyzed using STATA 14. Tests with P values <0.05 were considered statistically significant. Results: The frequency of vitamin D deficiency in the total population of children with UTI was, in case-control studies, and in cohort studies were 42%, 44%, and 38%, respectively. Furthermore, the rates of vitamin D deficiency in children with UTI aged under 3 years, those aged 3 to 5 years, and children older than 5 years were 21%, 46%, and 71%, respectively. Additionally, vitamin D insufficiency frequency in the total population of children with UTI, in case-control studies, and cross-sectional studies was 30%, 34%, and 22%, respectively. Moreover, the rates of vitamin D insufficiency in children with UTI aged under 3 years and those aged 3 to 5 years were 30% and 33%, respectively. Vitamin D deficiency was observed in 60% of the girls and 42% of the boys with UTI. Approximately 47% of the Asian and 20% of the European children with UTI suffered from vitamin D deficiency, and the frequency of vitamin D insufficiency in Asian and European children with UTI was 34% and 24%, respectively. Conclusion: Approximately half of the children with UTI suffered from vitamin D deficiency, and one-third of them faced vitamin D insufficiency. The increase in the age of the children added to the percentage of children with vitamin D deficiency or insufficiency. Furthermore, Asian children were at higher risk compared with European children, and females were exposed to higher risks than males. Registration: This study has been compiled based on the PRISMA checklist, and its protocol was registered on the PROSPERO (ID: CRD420251122224) and Research Registry (UIN: reviewregistry2033) websites.

19 December 2025
Verified
Journal Article
Closed access
Sina Salem AhimSina Salem Ahim
Sina Salem Ahim
MMMahnaz Mohammadnezhad
Mahnaz Mohammadnezhad
NBNilufar Bavafa
Nilufar Bavafa